Mounjaro Dosing Demystified: What Dose Should I Start On for Your Weight Loss Journey?

Last reviewed: July 16, 2026

Last updated: July 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in Mounjaro, works by activating two hormone pathways that regulate hunger and metabolism. Most patients begin at the lowest available dose and gradually increase over several months, a process called titration that allows your body to adapt while your provider monitors your progress and tolerance.

Understanding Tirzepatide Starting Doses and Titration Schedules

Tirzepatide weight loss treatment begins at a modest dose designed to introduce your system to the medication safely. The typical starting point is 2.5 mg once weekly, administered as a subcutaneous injection. This initial dose is subtherapeutic—meaning it's intentionally lower than the target dose—to allow your body to acclimate and for your provider to assess how you respond. Starting low reduces the likelihood of gastrointestinal side effects and helps establish a baseline for how your individual system tolerates the medication.

Every four weeks, your provider evaluates your tolerance and response, then considers increasing your dose by 2.5 mg increments. The standard titration ladder progresses as follows: 2.5 mg, then 5 mg, then 7.5 mg, then 10 mg, then 12.5 mg, and finally 15 mg as the maximum dose. However, not every patient needs to reach the highest dose to achieve significant weight loss. Clinical trials show that meaningful results occur across the entire dose range, and your provider's goal is finding the lowest effective dose that you tolerate well rather than automatically advancing to maximum strength.

Why Dosing Adjustments Depend on Your Individual Response

Your body's response to tirzepatide is highly individual and depends on factors including your baseline metabolism, insulin sensitivity, genetic predispositions, and previous medication experiences. Two patients starting at the same dose may have completely different tolerance profiles: one might progress smoothly through the titration schedule while another experiences side effects that require a slower advancement or stabilization at a lower dose. Your healthcare provider monitors not just your weight loss but also your appetite suppression, energy levels, gastrointestinal symptoms, and blood sugar improvements to determine whether continuing to increase is appropriate or whether your current dose is optimal.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Maintenance Doses and Long-Term Weight Loss Management

Once your provider identifies your optimal maintenance dose—the dose at which you experience good appetite control, consistent weight loss, and manageable side effects—you remain on that dose for as long as you continue treatment. Many patients stabilize at doses between 7.5 mg and 12.5 mg weekly, though some achieve excellent results at lower doses and others benefit from the 15 mg maximum. The key principle is that your dose may need to go up, but your price won't: PlexusDx charges a flat $289 per month for compounded tirzepatide injection regardless of whether you're at 2.5 mg or 15 mg, eliminating the financial pressure to escalate unnecessarily.

Long-term tirzepatide use requires ongoing partnership with your healthcare provider. Regular check-ins allow monitoring of your metabolic markers, appetite response, weight loss trajectory, and any side effects. Some patients plateau after several months of consistent weight loss, which is a normal biological response; your provider may adjust your dose slightly or recommend lifestyle modifications to continue progress. Others maintain steady results for extended periods without dose changes, demonstrating that tirzepatide's appetite-suppressing effects remain consistent with consistent dosing.

PlexusDx Access to Compounded Tirzepatide Without flat per-compound pricing

PlexusDx compounded tirzepatide injection is manufactured by licensed 503A compounding pharmacies and available to patients in all 50 states without insurance requirements or membership fees. Pricing is $289/mo month-to-month, or from $249/mo on the 6-month plan across three commitment tiers, with the guarantee that dose increases do not trigger price increases. Whether you're titrating from 2.5 mg or maintaining at 12.5 mg, your monthly investment remains consistent, making it easier to focus on your health rather than navigating confusing flat per-compound pricing structures.

PlexusDx also offers oral tirzepatide for patients who prefer tablets over injections, at $349/mo month-to-month, or from $279/mo on the 6-month plan with the same flat-pricing model. Additionally, patients can explore the Precision Peptide Genetic Test for $99 after their first month of treatment, providing personalized genetic insights to optimize their dosing strategy. All medications are HSA- and FSA-eligible, and PlexusDx accepts direct-to-patient ordering with rapid fulfillment, ensuring you begin your weight loss journey without delays.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What dose of tirzepatide should I start on for weight loss?

Most patients begin tirzepatide therapy at 2.5 mg once weekly, a low starting dose that allows your body to acclimate and your provider to assess tolerance. Your dose increases by 2.5 mg increments every four weeks based on your individual response, tolerance, and clinical progress. PlexusDx works with licensed compounding pharmacies to deliver your personalized dose at a flat $289 monthly rate, regardless of your dose level.

How fast does tirzepatide dosing increase?

The standard titration schedule increases your dose by 2.5 mg every four weeks, progressing from 2.5 mg up to a maximum of 15 mg weekly. However, your healthcare provider may slow, pause, or reverse this progression based on side effects, appetite response, weight loss results, and your overall tolerance. Some patients stabilize at lower doses and never reach the maximum, which is a successful outcome if you're achieving your health goals.

Does my tirzepatide price change when my dose increases?

No. PlexusDx charges a flat $289 per month for compounded tirzepatide injection regardless of whether you're receiving 2.5 mg or 15 mg weekly. This transparent pricing model ensures your dose can increase based on clinical need without financial surprise, and your HSA or FSA can cover the full amount.

What if I experience side effects at my current tirzepatide dose?

Gastrointestinal side effects like nausea are common during the early weeks of tirzepatide and often improve as your body adapts. If side effects persist or become severe, your PlexusDx provider may recommend slowing your titration schedule, extending the interval between dose increases, or temporarily pausing advancement while you remain on your current dose. Dose reduction is also an option if symptoms are intolerable.

How can PlexusDx's genetic test help with my tirzepatide dosing?

No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.